id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-5935-0001,FDA,FDA-2025-N-5935,"Intercept Pharmaceuticals, Inc., et al.; Withdrawal of Approval of New Drug Application for OCALIVA (Obeticholic Acid) Tablets, 5 Milligrams and 10
Milligrams, and Three Abbreviated New Drug Applications for Obeticholic Acid Tablets, 5 Milligrams and 10 Milligrams",Notice,Withdrawal,2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-24T18:52:14Z,2025-20767,0,0,09000064b90936f4